Skip to main content
. 2020 Feb 19;8(1):e000933. doi: 10.1136/bmjdrc-2019-000933

Table 2.

Factors associated with oxidative stress cross-sectionally

Parameter GLM results with continuous D-ROM as
dependent variable
Logistic regression results
with D-ROM >400 Carr U
as dependent variable
ß P value OR (95% CI)
Sex 55.17 <0.01 4.64 (4.16 to 5.16)
Education
 Low Ref Ref
 Medium 2.66 0.54 1.12 (0.99 to 1.27)
 High −5.81 0.27 0.57 (0.47 to 0.68)
BMI (kg/m²)
 <25 Ref Ref
 25–<30 −4.93 0.29 1.13 (0.98 to 1.31)
 30–<35 1.76 0.72 1.35 (1.16 to 1.57)
 35–<40 7.02 0.27 1.64 (1.35 to 1.98)
 ≥40 26.59 0.001 2.83 (2.25 to 3.55)
Smoking
 Never smoker Ref Ref
 Former smoker 3.46 0.32 1.20 (1.08 to 1.34)
 Current smoker, smoking 0–15 g
tobacco/day
30.09 <0.01 2.23 (1.82 to 2.74)
 Current smoker, smoking >15 g
tobacco/day
24.65 <0.01 2.17 (1.76 to 2.68)
HbA1c (%)
 <6 Ref Ref
 6–<7 1.48 0.73 1.06 (0.93 to 1.21)
 7–<8 10.35 0.04 1.32 (1.12 to 1.54)
 ≥8 4.08 0.53 1.38 (1.13 to 1.68)
Diabetes medication
 No Ref Ref
 Oral antidiabetics 15.50 <0.01 0.57 (0.51 to 0.63)
 Insulin −7.95 0.09 0.71 (0.62 to 0.82)
History of stroke 11.71 0.03 0.85 (0.72 to 1.02)
History of myocardial infarction 7.45 0.20 1.31 (1.08 to 1.56)
Coronary heart disease 4.24 0.33 1.05 (0.91 to 1.20)
Heart failure 15.10 <0.01 1.42 (1.25 to 1.62)
History of cancer 13.74 <0.01 1.50 (1.31 to 1.73)
Total cholesterol (mg/dL)
 <200 Ref Ref
 200–<280 11.86 <0.01 1.32 (1.19 to 1.47)
 ≥280 18.77 <0.01 1.54 (1.32 to 1.80)

Pooled effect estimates from the ESTHER type 2 diabetes subcohort (n=1045) and the DIANA study (n=1101).

All variables shown in the table were assessed simultaneously in the same multivariable model. Numbers shown were generated from a data set with imputed missing values.

Results in bold highlight statistically significant findings (P < 0.05).

BMI, body mass index; DIANA, Diabetes mellitus: Neue Wege der Optimierung der allgemeinärztlichen Betreuung; D-ROM, Diacron’s reactive oxygen metabolites; ESTHER, Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung; GLM, generalized linear model; HbA1c, glycated haemoglobin A1c.